Rush University Medical Center is a nationally ranked academic medical center in the Illinois Medical District neighborhood of Chicago, Illinois.

There are 664 beds in Rush University Medical Center ( Site 0040).

During the past decade, Rush University Medical Center ( Site 0040) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University Medical Center ( Site 0040)" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rush University Medical Center ( Site 0040)" are "Carcinoma, Renal Cell" (2 trials). Many other conditions were trialed in "Rush University Medical Center ( Site 0040)" in a lesser frequency.

Most popular intervention types in "Rush University Medical Center ( Site 0040)" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Belzutifan" (2 trials), "Lenvatinib" (2 trials), "Cabozantinib" (1 trials), "Pembrolizumab" (1 trials) and "Pembrolizumab/Quavonlimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush University Medical Center ( Site 0040)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rush University Medical Center ( Site 0040)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rush University Medical Center ( Site 0040), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush University Medical Center ( Site 0040), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".